Wernau Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.2M Buy
114,031
+149
+0.1% +$3.97K 2.23% 9
2025
Q4
$2.84M Sell
113,882
-8,259
-7% -$208K 1.53% 11
2025
Q3
$3.11M Sell
122,141
-2,183
-2% -$53.9K 2.12% 9
2025
Q2
$3.01M Sell
124,324
-41,320
-25% -$964K 2.09% 9
2025
Q1
$4.2M Buy
165,644
+12,096
+8% +$317K 3.28% 8
2024
Q4
$4.07M Buy
+153,548
New +$4.16M 3.04% 9

Other funds holding PFE

Wernau Asset Management's PFE Position: Q1 2026 in Review

Wernau Asset Management increased its Pfizer (PFE) stake by 0.13% in Q1 2026, buying an estimated $3.97K and bringing the position to 114,031 shares worth $3.2M. The position accounts for 2.23% of the portfolio, ranked #9.

Wernau Asset Management first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. The position peaked at $4.2M in Q1 2025. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Wernau Asset Management held 114,031 shares of Pfizer worth $3.2M as of Q1 2026.
  • Wernau Asset Management bought 149 Pfizer shares in Q1 2026, an estimated $3.97K.
  • Pfizer made up 2.23% of Wernau Asset Management's portfolio in Q1 2026, its #9 holding.
  • Wernau Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • Wernau Asset Management's Pfizer position peaked at $4.2M in Q1 2025.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Wernau Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.